News

Angioline became the main sponsor of the vi russian congress of interventional cardioangiologists

ANGIOLINE Company became the main sponsor of the VI Russian Congress of Interventional Cardioangiologists held on October 4-6, 2017 in Moscow. In addition to traditional reports and discussions, the Congress agenda also included the sessions completely devoted to live online broadcast of the X-ray guided endovascular procedures. Besides, the V International Course on Modern Trends in Managing Acute Myocardial Infarction with St Segment Elevation (ST-AMI): from Theory to Day-to-Day Practice took place within the framework of the Congress.
On Day 1 of the Congress, the ANGIOLINE Company arranged the Satellite Symposium for the Congress participants on Expending the Boundaries of the CALIPSO Stent Clinical Application for Better Results to Be Obtained, whereat the leading Russian cardiovascular and endovascular surgeons made reports. Thus, Professor of the Hospital Surgery Department of the RUDN University, Head of the Cardiovascular Surgery Department of the Center of Endosurgery and Lithotripsy, Multi-Discipline Clinic (CELT, MC), Doctor of Medicine Avtandil Babunashvili gave the detailed analysis of the CALIPSO stent application in a difficult clinical case, while Leading Researcher of the Academician E.N. Meshalkin’s National Medical Research Center, Evgeny Kretov made a report on Approaches to Increasing the Proportion of Drug-Eluting Stent’s Clinical Application: Long-Term Results of e-Calipso 2. The Symposium was opened by Medical Director of the Company, Oleg Volkov, who reviewed the improvements in the CALIPSO stent performance and the outcomes of its five-year application in medical practice.